TrialJournal of the American Society of Nephrology : JASN2017

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

David R W Jayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.